Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells
Language English Country Switzerland Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
18445770
DOI
10.3181/0802-rm-43
PII: 0802-RM-43
Knihovny.cz E-resources
- MeSH
- Adenosine analogs & derivatives pharmacology MeSH
- Adenosine A1 Receptor Agonists * MeSH
- Adenosine A3 Receptor Agonists * MeSH
- Bone Marrow Cells cytology drug effects metabolism MeSH
- Erythroid Cells cytology drug effects metabolism MeSH
- Granulocytes cytology drug effects metabolism MeSH
- Hematopoietic Stem Cells cytology drug effects metabolism MeSH
- Homeostasis physiology MeSH
- Mice, Inbred C57BL MeSH
- Mice, Inbred CBA MeSH
- Mice MeSH
- Cell Proliferation drug effects MeSH
- Receptor, Adenosine A1 metabolism MeSH
- Receptor, Adenosine A3 metabolism MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adenosine MeSH
- Adenosine A1 Receptor Agonists * MeSH
- Adenosine A3 Receptor Agonists * MeSH
- N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine MeSH Browser
- N(6)-cyclopentyladenosine MeSH Browser
- Receptor, Adenosine A1 MeSH
- Receptor, Adenosine A3 MeSH
Two adenosine receptor agonists, N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and N6-cyclopentyladenosine (CPA), which selectively activate adenosine A3 and A1 receptors, respectively, were tested for their ability to influence proliferation of granulocytic and erythroid cells in femoral bone marrow of mice using morphological criteria. Agonists were given intraperitoneally to mice in repeated isomolar doses of 200 nmol/kg. Three variants of experiments were performed to investigate the action of the agonists under normal resting state of mice and in phases of cell depletion and subsequent regeneration after treatment with the cytotoxic drug 5-fluorouracil. In the case of granulopoiesis, IB-MECA 1) increased by a moderate but significant level proliferation of cells under normal resting state; 2) strongly increased proliferation of cells in the cell depletion phase; but 3) did not influence cell proliferation in the regeneration phase. CPA did not influence cell proliferation under normal resting state and in the cell depletion phase, but strongly suppressed the overshooting cell proliferation in the regeneration phase. The stimulatory effect of IB-MECA on cell proliferation of erythroid cells was observed only when this agonist was administered during the cell depletion phase. CPA did not modulate erythroid proliferation in any of the functional states investigated, probably due to the lower demand for cell production as compared with granulopoiesis. The results indicate opposite effects of the two adenosine receptor agonists on proliferation of hematopoietic cells and suggest the plasticity and homeostatic role of the adenosine receptor expression.
References provided by Crossref.org
The role of adenosine receptor agonists in regulation of hematopoiesis